MCH ANALYSIS RESEARCHMain site ↗
Daily

Today

What the book says now, and what moved since the last run. Each feed carries its own date. Equity research as of 2026-10-13 (today) Options chain as of 2026-10-12 · 1d old Regime as of 2026-10-13 (today)

Market state

Authoritative HALT · options stance: Defensive · hedge: 1.5× · as of 2026-10-13

Shadow · experimental Mid-cycle · Constructive / Stable · as of 2026-10-13

Full regime analysis →

What changed

Estate: 2026-10-13 vs previous run 2026-10-12 · 921 names now, 921 then. What each estate count counts →

  • 17 Rating changes — AAL HOLD→BUY · ALK HOLD→BUY · AMAT HOLD→BUY · BURL HOLD→BUY · CVS BUY→HOLD · ELV HOLD→SELL · +11 more
    Show the other 11LSCC SELL→HOLD · NKE BUY→HOLD · POST BUY→HOLD · RMBS SELL→HOLD · RRC HOLD→SELL · SRE BUY→HOLD · VFC BUY→HOLD · VIAV SELL→HOLD · VRT HOLD→BUY · VVV HOLD→BUY · WEC BUY→HOLD
  • 18 Expected-return moves (≥5 pp)
  • 54 Conviction moves (≥5 pts)

Shadow · experimental The six dimensions read credit neutral, growth expanding, inflation disinflating, internals neutral, policy restrictive, volatility normal. Changed since the last snapshot: internals moved from deteriorating to neutral. Largest twenty-session moves: Initial jobless claims 197,000 (0th percentile), -13,000 over twenty sessions; ICE BofA CCC & lower OAS 12.52 (100th percentile), +1.82 over twenty sessions. Data quality: degraded (1 stale, 0 unresolved).

Where to look first

top 3 of each registered ranking — all rankings →
Ranking#1#2#3
Highest MCH Estimated 12-Month ReturnBROS +81.6%XRAY +73.1%BLDR +70.3%
Best Bull / Bear Scenario RatioBROS 11.9×XRAY 9.3×BLDR 8.7×
Highest QualityVEEV 98/100SCHW 98/100QLYS 98/100

Options analytics

Of 5,068 option structures assessed across the covered chains, 4,412 (87%) carry a negative confidence-adjusted expected value once the cost of crossing the spread is charged. Contract-specific structures are not published. Options analytics and strategy education →

Catalysts — 2026-10-14 to 2026-10-20

DateEvents
2026-10-14ACM Ex-dividend $0.31/sh · BAC Quarterly earnings · BIIB Leqembi subcutaneous maintenance formulation launch / uptake milestone · BLK Quarterly earnings · BLK Private-markets fundraising and GIP/HPS/Preqin integration milestone at Q3 earnings · CRM Agentforce enterprise-deployment cohort data / large-customer expansion proof points · CTAS Investor update on cross-sell penetration and tuck-in M&A pipeline · FAST Quarterly earnings +9 more · September CPI
2026-10-15AA Quarterly earnings · ABBV Ex-dividend $1.73/sh · ABT Ex-dividend $0.63/sh · AEE Missouri (MoPSC) electric rate-case order / Illinois multi-year rate plan update · AFG Ex-dividend $0.97/sh · AIZ Major mobile-carrier device-protection contract renewal window · ALGN New-generation Invisalign/iTero product launch cycle · ALL Auto rate-adequacy / margin-recovery confirmation across key states +67 more
2026-10-16AYI Ex-dividend $0.20/sh · CFG Quarterly earnings · CFG Investor day / medium-term ROTCE and NIM target update · CSX FY2027 volume, pricing and operating-ratio guidance framework · EOG Ex-dividend $1.02/sh · MTB Quarterly earnings · RF Quarterly earnings · SNX Ex-dividend $0.48/sh +4 more
2026-10-19CCK Quarterly earnings · CLF Quarterly earnings · DOC Ex-dividend $0.10/sh · FITB Quarterly earnings · FNB Quarterly earnings · OC Ex-dividend $0.79/sh · RLI Quarterly earnings · STLD Quarterly earnings +5 more
2026-10-20A Analyst/Investor Day — Ignite strategy and FY2027 margin bridge · ADC Quarterly earnings · ALK Quarterly earnings · ALLY Quarterly earnings · AMP Advisor-recruitment and net-flow trend update · CB Quarterly earnings · CBSH Quarterly earnings · CL Ex-dividend $0.53/sh +50 more

Dated earnings exist for 821 of 916 actively covered names. A missing row means no date on file, not no event.

Risk & integrity

Exception register: 916 = 860 fresh + 4 caveat + 52 exceptions — every withheld name is named with its reason on /governance.

Focus Research Basket modelled volatility 9.2% (annualised) — basket risk and methodology →

MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.21.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies